Spots Global Cancer Trial Database for zometa
Every month we try and update this database with for zometa cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) | NCT01204203 | Mesothelioma | Zometa | 19 Years - | University of Alabama at Birmingham | |
| Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis | NCT00762346 | Non Small Cell ... Bone Metastases High NTX Level | zometa | 18 Years - | Sun Yat-sen University | |
| PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | NCT01205646 | Prostate Cancer | zoledronate the... PET Scan | - | Barbara Ann Karmanos Cancer Institute | |
| Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone | NCT00181558 | Prostate Cancer Adenocarcinoma ... | Atrasentan Zoledronic Acid... | 18 Years - | Massachusetts General Hospital | |
| ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases | NCT00294437 | Prostate Cancer | Zometa | 18 Years - | Central European Cooperative Oncology Group | |
| Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) | NCT00712985 | Breast Cancer | Zometa | 18 Years - | Milton S. Hershey Medical Center | |
| Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer | NCT00181584 | Bone Loss Prostate Cancer | Zoledronic acid Placebo | 18 Years - | Massachusetts General Hospital | |
| Zoledronate With Atorvastatin in Renal Cell Carcinoma | NCT00490698 | Kidney Cancer Renal Cell Carc... | Zoledronate Atorvastatin | - | M.D. Anderson Cancer Center | |
| Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) | NCT00712985 | Breast Cancer | Zometa | 18 Years - | Milton S. Hershey Medical Center | |
| Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy | NCT00582556 | Prostate Cancer | Zometa zometa Zometa | 18 Years - | University of Wisconsin, Madison | |
| Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer | NCT00265200 | Carcinoma, Non-... Carcinoma, Smal... Metastases | zoledronic acid | 18 Years - | University of Louisville | |
| Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis | NCT00762346 | Non Small Cell ... Bone Metastases High NTX Level | zometa | 18 Years - | Sun Yat-sen University | |
| Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer | NCT00760370 | Multiple Myelom... Breast Cancer | Zoledronic Acid | - | Vejle Hospital | |
| Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate | NCT00151073 | Hormone-Refract... | Zoledronic acid Estramustine Docetaxel | 18 Years - | University of Michigan Rogel Cancer Center | |
| PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | NCT01205646 | Prostate Cancer | zoledronate the... PET Scan | - | Barbara Ann Karmanos Cancer Institute | |
| Zoledronate With Atorvastatin in Renal Cell Carcinoma | NCT00490698 | Kidney Cancer Renal Cell Carc... | Zoledronate Atorvastatin | - | M.D. Anderson Cancer Center | |
| Stage I Multiple Myeloma Treatment | NCT00733538 | Multiple Myelom... | zometa | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer | NCT00760370 | Multiple Myelom... Breast Cancer | Zoledronic Acid | - | Vejle Hospital | |
| Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) | NCT01204203 | Mesothelioma | Zometa | 19 Years - | University of Alabama at Birmingham | |
| Stage I Multiple Myeloma Treatment | NCT00733538 | Multiple Myelom... | zometa | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | NCT00035997 | Prostate Cancer | Zometa | 18 Years - | Novartis | |
| Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers | NCT01367288 | Locally Advance... Ductal Histolog... Without Her 2 O... | Zometa + Neoadj... Neoadjuvant the... | 18 Years - | Hospices Civils de Lyon | |
| Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis | NCT00762346 | Non Small Cell ... Bone Metastases High NTX Level | zometa | 18 Years - | Sun Yat-sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
